← All stocks

TAKEDA PHARMACEUTICAL CO LTD

TAK Net selling
CIK 0001395064 #575 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.09M
$2.51M on a plan · $0.00 straight out of an exercise
Sold at will
$10.58M
18 of 20 sales
Net
−$13.09M
−$10.58M against sales at will

By person

25 insiders · 20 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Plump Andrew Stewart
President, R&D
$5.34M (3)
−$5.34M
1,173,690
$21.76M
+3.2%
Kim Julie So-Young
President and CEO
$1.52M (1)
−$1.52M
414,289
$7.68M
+27.6%
Duprey Lauren Rusckowski
Chief Transformation Officer
$1.45M (2)
−$1.45M
191,522
$3.55M
+13.7%
Greenway Nicola Deidre Petal
Chief Human Resources Officer
$956.73K (4)
−$956.73K
40,049
$742.51K
−44.2%
Bitetti Teresa Marie
President, OBU
$855.21K (1)
−$855.21K
252,010
$4.67M
+30.5%
Platford Giles Richard
President, IBU
$531.52K (1)
−$531.52K
315,838
$5.86M
+40.2%
Furney Natalie Anne Marie
Global General Counsel
$527.84K (1)
−$527.84K
204,298
$3.79M
+6.8%
Ricci Gabriele
Chief Data & Tech. Officer
$429.00K (1)
−$429.00K
171,654
$3.18M
+38.3%
Shannon Elaine Mary
Pres., Global Supply & Quality
$425.39K (2)
−$425.39K
67,311
$1.25M
+9.3%
Pignagnoli Agosti Marcello
Head, Strat. & Port. Dev
$392.56K (1)
−$392.56K
176,977
$3.28M
+22.4%
Pacheco Rhonda Janice
President, U.S. Business Unit
$289.01K (1)
−$289.01K
182,507
$3.38M
+22.3%
Farajallah Awny Samaan Botros
Chief Medical Officer
$239.50K (1)
−$239.50K
116,177
$2.15M
+3.2%
Ibrahim Ramy Riad Ahmed
President, PDT BU
$124.44K (1)
−$124.44K
102,588
$1.90M
+21.0%
Weber Christophe Pierre
President and CEO
1,433,003
$26.57M
+20.5%
Furuta Milano
Chief Financial Officer
70,200
$1.30M
+40.1%
Smoter Jennifer Marie
Chief Comm. & Gov. Officer
18,808
$348.70K
Iijima Masami
Director
14,601
$270.70K
+14.1%
GILLIS STEVEN
Director
10,400
$192.82K
+57.6%
MARAGANORE JOHN
Director
10,400
$192.82K
+57.6%
Reed Kimberly A.
Director
10,400
$192.82K
+57.6%
Tsusaka Miki
Director
8,200
$152.03K
+28.1%
BROUSSARD BRUCE D
Director
4,595
$85.19K
+478.0%
Miyabashira Asuka
President, Japan Pharma B.U.
4,500
$83.43K
+50.0%
Stoffels Paulus
Director
3,800
$70.45K
Kimura Koichiro
Director
1,800
$33.37K

No percentages here. TAKEDA PHARMACEUTICAL CO LTD reports its share count only per share class, which the XBRL frames API does not carry.

Insider
Date
Role
Action
Shares
Price
Amount
Plump Andrew Stewart
2 Sep 2026
President, R&D
Sold on a plan indirect
116,191
$18.49
$2.15M
Plump Andrew Stewart
19 Aug 2026
President, R&D
Sold on a plan indirect
19,651
$18.49
$363.35K

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 0
Filings about a different issuer 39
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 18
Transactions with no price 0
Shares from compensation/vesting 1,478,548
History held since 21 Mar 2018